MedTech Meetup NYC | From Idea to Impact
A Practical Roadmap for Building a MedTech Company Ready for HCPs, Patients, Partners, Investors & the Market
October 22, 2026 | 5:30 PM
Pearl Cohen Offices | Times Square, New York City
Building a successful MedTech company takes more than great technology.
Join us for an intimate evening bringing together MedTech founders, executives, investors, and industry experts to explore the critical decisions that shape a company’s journey from early innovation to market entry.
Through four focused expert perspectives and an interactive panel, we’ll explore how legal & IP strategy, clinical evidence, reimbursement & market access, and commercial brand strategy need to work together from the earliest stages.
Moderator
Guy Milhalter | Pearl Cohen
Guy Milhalter is a Partner at Pearl Cohen LLP. Guy is a business-minded technology transactions attorney who advises technology companies, startups, and health IT companies on complex, strategic transactions. He regularly counsels clients on legal risk, governance, and the commercial deployment of AI technologies. Guy frequently supports legal and business teams in fast-paced environments where deal execution, regulatory compliance, and business strategy intersect.
Featured Speakers
Cheli Gonnen | R.S NESS Group
Turning Medical Innovation into Clinical Evidence
Cheli Gonnen is the Head of the CRO and Clinical Department at R.S. NESS. With more than 20 years of experience supporting pharmaceutical and medical device companies, she combines clinical strategy, regulatory expertise, study management, and hands-on execution to help sponsors successfully plan and conduct clinical studies in Israel and worldwide.
Leana Silverberg | PHIE
Designing a MedTech Product the Market Will Pay For
Leana Silverberg is a consultant who combines her M.Sc. in biotech, MPH, and MBA to help health innovations navigate commercialization. As a Stanford fellow, she focused on regulatory, reimbursement, and adoption challenges for novel health technologies. Her experience includes co-founding a drug discovery tools company, co-developing a COVID-19 screening technique, leading a newborn health nonprofit, and advising 60+ health technology companies. She also mentors entrepreneurs through Techstars, MedTech Innovator, Johns Hopkins, and UCSF.
Morey Wildes | Pearl Cohen
Legal Foundation and Intellectual Property
Morey Wildes is a Partner at Pearl Cohen LLP, focusing on counseling clients seeking patent, trademark, and trade secret rights. Morey handles the prosecution of patent and trademark applications, licensing of intellectual property rights, and opinions of patentability and freedom to operate. His experience includes a broad variety of products and complex technologies, including external and implantable medical devices, computer software and Internet application programs, automotive engines and exteriors, digital signatures and cryptography systems, chemical delivery systems, and other consumer products.
Scott Shevrin | The Jump
Building the Brand and the Market for Launch
Scott Shevrin is Co-Founder of The Jump, a strategic creative consultancy that helps medtech, healthtech, and diagnostics companies build brand identity, positioning, and go-to-market strategies and creative campaigns that translate complex innovation into clear market opportunity. With extensive healthcare commercial strategy experience — including executive roles at McCann Health, Wunderman Thompson Health, and Havas Life — Scott brings senior-level expertise directly to early- and growth-stage companies navigating launch, funding, and market adoption. The Jump partners closely with founders and leadership teams to deliver the creative and strategic clarity needed to compete and grow.
What to Expect
What Early-Stage MedTech Companies Must Get Right — and What They Often Get Wrong
We’ll discuss practical questions around early-stage priorities, investor readiness, U.S. market entry, clinical strategy, reimbursement, commercialization, and the mistakes that become increasingly expensive to correct later.
The evening will conclude with audience Q&A and networking.
Who Should Attend?
MedTech & Digital Health founders, CEOs and executives, investors, innovation leaders, and other professionals involved in bringing medical technologies to market.
October 22, 2026 | 5:30 PM
Midtown Manhattan , New York City
Space is limited. Registration required.